This event has ended. Visit the official site or create your own event on Sched.


Scott Andersen

Eli Lilly and Company
Principal Research Scientist
Scott has been a statistician designing and analyzing neuroscience clinical trials for nearly 20 years. While most of his research has focused on depression and schizophrenia disease states, Scott has spent the last five years working on Alzheimer's Disease. In 2015, Scott co-authored two Delayed Start manuscripts with Hong Liu-Seifert.

My Speakers Sessions

Tuesday, June 28

2:00pm EDT